Combination therapy shows promise in treating advanced ER+ breast cancer

[News]

Advanced estrogen receptor-positive (ER+) breast cancer can be especially difficult to treat. A new study by researchers at Dartmouth Cancer Center led by Todd W. Miller, PhD, shows promise in using a combination of estrogen and a PARP inhibitor (a drug that suppresses DNA damage repair), to treat this type of cancer.

More... (https://www.news-medical.net/news/20230713/Combination-therapy-shows-promise-in-treating-advanced-ER2b-breast-cancer.aspx)